Tag: hypercholesterolemia
Merck: launch of a hypercholesterolemia program – 08/25/2023 at 14:13
(CercleFinance.com) – Merck (MSD excluding the United States and Canada) announces the launch of its CORALreef phase III clinical program to evaluate MK-0616, an investigational oral PCSK9 inhibitor, in the…
Merck and co inc: Launch of a hypercholesterolemia program
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…
Hypercholesterolemia: systematic screening to avoid heart attacks?
Yasmina Kattou, edited by Alexandre Dalifard 07:07, October 28, 2022modified to 11:06 a.m., October 28, 2022 Today, 40,000 children are said to be living with higher than normal cholesterol levels…
Valbiotis presents the positive complementary results of the HEART clinical study on TOTUM•070 against hypercholesterolemia – 03/10/2022 at 07:35
• TOTUM•070 obtains excellent results in volunteers who had a blood level of LDL cholesterol greater than 130 mg/dl at randomization, its commercially targeted population and main subpopulation of the…
Valbiotis announces the broad success of the HEART Phase II clinical study: TOTUM•070, a patented plant-based active substance, demonstrates its efficacy against hypercholesterolemia, a cardiovascular risk factor – 06/13/2022 at 6:30 p.m.
• This Phase II clinical study with TOTUM•070, randomized and controlled against placebo, achieves its objective of reducing LDL cholesterol (primary endpoint) and confirms the very good tolerance of this…
Hypercholesterolemia: solutions on a case-by-case basis: Femme Actuelle Le MAG
Hypercholesterolemia: solutions on a case-by-case basis: Femme Actuelle Le MAG Path 2 645DBCB3-7979-441A-BA4B-98E7BF17E1BE 1785B508-2A96-4CF5-AA87-79B0FE0441BF advertising source site-44
Familial hypercholesterolemia, a silent disease: Femme Actuelle Le MAG
Familial hypercholesterolemia, a silent disease: Femme Actuelle Le MAG Path 2 645DBCB3-7979-441A-BA4B-98E7BF17E1BE 1785B508-2A96-4CF5-AA87-79B0FE0441BF advertising source site